The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Khryanin A.A.

Novosibirsk State Medical University;
Association of obstetrician-gynecologists and dermatologists

Sokolovskaia A.V.

Novosibirsk State Medical University

Chernikova E.V.

Novosibirsk State Medical University

Bocharova V.K.

Pavlov First Saint Petersburg State Medical University

Hidradenitis suppurativa: main aspects of disease, management

Authors:

Khryanin A.A., Sokolovskaia A.V., Chernikova E.V., Bocharova V.K.

More about the authors

Read: 5422 times


To cite this article:

Khryanin AA, Sokolovskaia AV, Chernikova EV, Bocharova VK. Hidradenitis suppurativa: main aspects of disease, management. Russian Journal of Clinical Dermatology and Venereology. 2023;22(6):661‑668. (In Russ.)
https://doi.org/10.17116/klinderma202322061661

Recommended articles:
Search of diagnostic and prognostic biomarkers of immu­noinflammatory dermatoses by means of flow cyto­metry. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):170-177

References:

  1. Nguyen TV, Damiani G, Orenstein LA. Hidradenitis suppurativa: An update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol. 2021;35:50-61. 
  2. Egeberg A, Jemec GB, Kimball AB, et al. Prevalence and risk of inflammatory bowel disease in patients with hidradenitis suppurativa. J Invest Dermatol. 2017;137:1060-1064.
  3. Vazquez BG, Alikhan A, Weaver AL. Incidence of hidradenitis suppurativa and associated factors: A population-based study of Olmsted county, Minnesota. J Invest Dermatol. 2013;133:97-103. 
  4. Revuz J. Hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2009;23: 985-998. 
  5. Sartorius K, Emtestam L, Jemec G, Lapins J. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol. 2009;161:831-839. 
  6. Marzano A, Genovese G, Casazza G, et al. Evidence for ‘Window of opportunity’in hidradenitis suppurativa treated with adalimumab: A retrospective, real-life multicentre cohort study. Br J Dermatol. 2021;184:133-140. 
  7. Navrazhina K, Frew JW, Gilleaudeau P. Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa. J Allergy Clin Immunol. 2021; 147:2213-2224.
  8. Canoui-Poitrine F, Revuz JE, Wolkenstein P, et al. Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol. 2009; 61:51-57. 
  9. Brochhausen C, Babel M, Schmitt V, et al. Skin ulcerations due to CINCA syndrome and its successful treatment with prostaglandin E1. Z Rheumatol. 2018;77:633-636. 
  10. Marzano A, Damiani G, Ceccherini I. Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis) Br J Dermatol. 2017;176:1588-1598.
  11. Renata F, Kristian L, Federica F. The impact of autoimmune systemic inflammation and associated medications on male reproductive health in patients with chronic rheumatological, dermatological, and gastroenterological diseases:A systematic review. Am J Reprod Immunol. 2021;85:e13389.
  12. Theut Riis P, Ring HC, Themstrup L. The role of androgens and estrogens in hidradenitis suppurativa — A systematic review. Acta Dermatovenerol Croat. 2016;24:239-249. 
  13. Sivanand A, Gulliver WP, Josan CK. Weight loss and dietary interventions for hidradenitis suppurativa:A systematic review. J Cutan Med Surg. 2020; 24:64-72. 
  14. Boer J, Jemec GB. Mechanical stress and the development of pseudo-comedones and tunnels in Hidradenitis suppurativa/Acne inversa. Exp Dermatol. 2016;25:396-397. 
  15. Boer J, Nazary M, Riis PT. The role of mechanical stress in hidradenitis suppurativa. Dermatol Clin. 2016;34:37-43. 
  16. Sartorius K, Emtestam L, Jemec G, Lapins J. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol. 2009;161:831-839. 
  17. Hana A, Booken D, Henrich C, et al. Functional significance of non-neuronal acetylcholine in skin epithelia. Life Sci. 2007;80:2214-2220.
  18. Jafari SMS, Knüsel E, Cazzaniga S, Hunger RE. A retrospective cohort study on patients with hidradenitis suppurativa. Dermatology. 2018;234:71-78. 
  19. Danby FW. Diet in the prevention of hidradenitis suppurativa (Acne inversa). J Am Acad Dermatol. 2015;73(5 suppl 1):52-54. 
  20. Zouboulis C, Desai N, Emtestam L, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015;29:619-644. 
  21. Yazdanyar S, Jemec GB. Hidradenitis suppurativa: A review of cause and treatment. Curr Opin Infect Dis. 2011;24:118-123. 
  22. Sabat R, Chanwangpong A, Schneider-Burrus S, et al. Increased prevalence of metabolic syndrome in patients with acne inversa. PloS One. 2012;7: e31810.
  23. Qian G Liu T, Zhou C, Zhang Y. Naevus comedonicus syndrome complicated by hidradenitis suppurativa-like lesions responding to acitretin treatment. Acta Derm Venereol. 2015;95:992-993. 
  24. Hobeish MM, Shustov DV, Sokolovsky EV. Suppurative hydradenitis: modern ideas about pathogenesis, therapy and successful experience of treatment with adalimumab. Bulletin of Dermatology and Venereology. 2017;5:70-81. (In Russ.). https://doi.org/10.25208/0042-4609-2017-93-5-70-81
  25. Guet-Revillet H, Coignard-Biehler H, Jais JP, et al. Bacterial pathogens associated with hidradenitis suppurativa, France. Emerg Infect Dis. 2014;20(12): 1990-1998. PMID: 25418454. PMCID: PMC4257786. https://doi.org/10.3201/eid2012.140064
  26. Burova SA, Potekaev NN, Borodulina KS. Purulent hydradenitis: prevalence, etiopathogenesis, comorbidity (Part 1). Russian Journal of Clinical Dermatology and Venereology = Klinichaskaya dermatologiya i venerologiya. 2019;18(2):111-114. (In Russ.). https://doi.org/10.17116/klinderma201918021111]
  27. Mishinev SV, Karchalova AM, Stupak VV, Serpeninova NN. Actinomycotic granuloma simulating malignant neoplasm of the brain. Questions of Neurosurgery named after N.N. Burdenko. 2015;5:63-67. (In Russ.). https://doi.org/10.17116/neiro201579563-67
  28. Boyanova L, Kolarov R, Mateva L, Markovska R, Mitov I. Actinomycosis: a frequently forgotten disease. Future Microbiol. 2015;10(4):613-628.  https://doi.org/10.2217/fmb.14.130
  29. Gajdács M, Urbán E, Terhes G. Microbiological and clinical aspects of cervicofacial Actinomyces infections: an overview. Dent J. 2019;7(3):85.  https://doi.org/10.3390/dj7030085
  30. Breton AL, Lamblin G, Pariset C, Jullien D. Cutaneous Actinomycosis associated with anti-TNF-alpha therapy: report of two cases. Dermatology. 2014;228(2):112-114.  https://doi.org/10.1159/000357522
  31. Khryanin AA, Sokolovskaya AV, Markarian DR, et al. Diseases of the skin of the perineum and perianal area. M.: GEOTAR-Media; 2022. (In Russ.).
  32. Khryanin AA, Markaryan DR, Garmanova TN, Bocharova VK. Dermatoses of the perianal area. Part 1. Russian Journal of Clinical Dermatology and Venereology = Klinichaskaya dermatologiya i venerologiya. 2021;20(3):69-75. (In Russ.). https://doi.org/10.17116/klinderma20212003169
  33. Könönen E, Wade WG. Actinomyces and related organisms in human infections. Clin Microbiol Rev. 2015;28(2):419-442.  https://doi.org/10.1128/CMR.00100-14
  34. Pulverer G, Schütt-Gerowitt H, Schaal KP. Human cervicofacial Actinomycoses: microbiological data for 1997 cases. Clin Infect Dis. 2003;37(4): 490-497.  https://doi.org/10.1086/376621
  35. Valour F, Sénéchal A, Dupieux C, et al. Actinomycosis: etiology, clinical features, diagnosis, treatment, and management. Infect Drug Resist. 2014; 7:183. 
  36. Jeong YJ, Suh HW, Shim HS. Cervicofacial Primary Cutaneous Actinomycosis: Surgical Treatment for Complete Remission of the Disease. J Craniofac Surg. 2017;28:e269.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.